95-17118. Manufacturer of Controlled Substances; Notice of Application  

  • [Federal Register Volume 60, Number 134 (Thursday, July 13, 1995)]
    [Notices]
    [Page 36164]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 95-17118]
    
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF JUSTICE
    Drug Enforcement Administration
    
    
    Manufacturer of Controlled Substances; Notice of Application
    
        Pursuant to Sec. 1301.43(a) of Title 21 of the Code of Federal 
    Regulations (CFR), this is notice that on May 18, 1995, Applied Science 
    Labs, Division of Alltech Associates, Inc., 2701 Carolean Industrial 
    Drive, P.O. Box 440, State College, Pennsylvania 16801, made 
    application to the Drug Enforcement Administration (DEA) for 
    registration as a bulk manufacturer of the basic classes of controlled 
    substances listed below:
    
    ------------------------------------------------------------------------
                               Drug                               Schedule  
    ------------------------------------------------------------------------
    Methcathinone (1237)......................................  I           
    N-Ethylamphetamine (1475).................................  I           
    N,N-Dimethylamphetamine (1480)............................  I           
    4-Methylaminorex (cis isomer) (1590)......................  I           
    Lysergic acid diethylamide (7315).........................  I           
    Mescaline (7381)..........................................  I           
    3,4-Methylenedioxyamphetamine (7400)......................  I           
    N-Hydroxy-3,4-methylenedioxyamphetamine (7402)............  I           
    3,4-Methylenedioxy-N-ethylamphetamine (7404)..............  I           
    3,4-Methylenedioxymethamphetamine (7405)..................  I           
    N-Ethyl-1-phenylcyclohexylamine (7455)....................  I           
    1-(1-Phenylcyclohexyl)pyrrolidine (7458)..................  I           
    1-[1-(2-Thienyl)cyclohexyl]piperidine (7470)..............  I           
    Dihydromorphine (9145)....................................  I           
    Normorphine (9313)........................................  I           
    1-Phenylcyclohexylamine (7460)............................  II          
    Phencyclidine (7471)......................................  II          
    Phenylacetone (8501)......................................  II          
    1-Piperidinocyclohexanecarbonitrile (8603)................  II          
    Cocaine (9041)............................................  II          
    Codeine (9050)............................................  II          
    Dihydrocodeine (9120).....................................  II          
    Benzoylecgonine (9180)....................................  II          
    Morphine (9300)...........................................  II          
    Oxymorphone (9652)........................................  II          
    ------------------------------------------------------------------------
    
        The firm plans to manufacture small quantities of these controlled 
    substances for reference standards.
        Any other such applicant and any person who is presently registered 
    with DEA to manufacture such substances may file comments or objections 
    to the issuance of the above application and may also file a written 
    request for a hearing thereon in accordance with 21 CFR 1301.54 and in 
    the form prescribed by 21 CFR 1316.47.
        Any such comments, objections, or requests for a hearing may be 
    addressed to the Deputy Assistant Administrator, Office of Diversion 
    Control, Drug Enforcement Administration, United States Department of 
    Justice, Washington, DC 20537, Attention: DEA Federal Register 
    Representative (CCR), and must be filed no later than August 14, 1995.
    
        Dated: July 5, 1995.
    Gene R. Haislip,
    Deputy Assistant Administrator, Office of Diversion Control, Drug 
    Enforcement Administration.
    [FR Doc. 95-17118 Filed 7-12-95; 8:45 am]
    BILLING CODE 4410-09-M
    
    

Document Information

Published:
07/13/1995
Department:
Drug Enforcement Administration
Entry Type:
Notice
Document Number:
95-17118
Pages:
36164-36164 (1 pages)
PDF File:
95-17118.pdf